Mattias Höglund
31 – 45 of 161
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Molecular classification of urothelial carcinoma : global mRNA classification versus tumour-cell phenotype classification
(
- Contribution to journal › Article
-
Mark
Genetic Alterations in the Molecular Subtypes of Bladder Cancer : Illustration in the Cancer Genome Atlas Dataset
(
- Contribution to journal › Scientific review
-
Mark
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Frequent miRNA-convergent fusion gene events in breast cancer
(
- Contribution to journal › Article
-
Mark
Cell-Type-Specific Gene Programs of the Normal Human Nephron Define Kidney Cancer Subtypes
(
- Contribution to journal › Article
-
Mark
HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts
(
- Contribution to journal › Article
- 2016
-
Mark
An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
(
- Contribution to journal › Article
-
Mark
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
(
- Contribution to journal › Article
-
Mark
Sätt fokus på blåscancer
(
- Contribution to specialist publication or newspaper › Specialist publication article
- 2015
-
Mark
Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma.
(
- Contribution to journal › Article
-
Mark
Biological determinants of bladder cancer gene expression subtypes.
(
- Contribution to journal › Article
-
Mark
Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems.
(
- Contribution to journal › Article
-
Mark
Heterogeneous Challenges for Urologic Cancers.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma.
(
- Contribution to journal › Article
-
Mark
Reply from Authors re: Bas W.G. van Rhijn, Mark A. Behrendt, Kees Hendricksen, Theo H. van der Kwast. Toward Optimal Prediction of Prognosis in T1 Urothelial Carcinoma of the Bladder. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.03.030.
(
- Contribution to journal › Debate/Note/Editorial